Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. [electronic resource]
- Innate immunity Apr 2014
- 249-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1753-4267
10.1177/1753425913488429 doi
Animals Cytokines--biosynthesis Dopaminergic Neurons--drug effects Immunohistochemistry Inflammation--drug therapy MPTP Poisoning--drug therapy Macrophage Activation--drug effects Male Mice Mice, Inbred C57BL Neostriatum--metabolism Neuroglia--drug effects Neuroprotective Agents--therapeutic use Real-Time Polymerase Chain Reaction Resveratrol Stilbenes--therapeutic use Substantia Nigra--metabolism Suppressor of Cytokine Signaling 1 Protein Suppressor of Cytokine Signaling Proteins--biosynthesis Tyrosine 3-Monooxygenase--metabolism Up-Regulation--drug effects